| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 03/04/2015 | EP2842547A1 Improved fenofibrate compositions |
| 03/04/2015 | EP2842546A1 Unit structure-type pharmaceutical composition for nucleic acid delivery |
| 03/04/2015 | EP2842545A1 Method for producing an aqueous dispersion of drug nanoparticles and use thereof |
| 03/04/2015 | EP2842481A1 Hydrogel implant for sensors for metabolites in body tissue |
| 03/04/2015 | EP2842428A1 Oral composition |
| 03/04/2015 | EP2841112A1 Porphyrin-lipid stabilized nanoparticles for surface enhanced raman scattering based imaging |
| 03/04/2015 | EP2841108A1 Silk microspheres and methods for surface lubrication |
| 03/04/2015 | EP2841106A1 Topical formulation compositions containing silicone based excipients to deliver actives to a substrate |
| 03/04/2015 | EP2841105A1 Magnesium phosphate gels |
| 03/04/2015 | EP2841064A1 Use of n-acetylcysteine amide in the treatment of disease and injury |
| 03/04/2015 | EP2841059A2 Implantable bioartificial perfusion system |
| 03/04/2015 | EP2841058A1 Delazed release pharmaceutical compositions of salsalate |
| 03/04/2015 | EP2841057A1 Crystalline microspheres and the process for manufacturing the same |
| 03/04/2015 | EP2841056A1 Stable layer-by-layer coated particles |
| 03/04/2015 | EP2841055A1 Methods of using cerium oxide nanoparticles to mitigate or protect against radiation injury |
| 03/04/2015 | EP2841054A1 Injectable preparation |
| 03/04/2015 | EP2841053A1 Treatment method for steroid responsive dermatoses |
| 03/03/2015 | US8969415 Intraocular drug delivery systems |
| 03/03/2015 | US8969414 Intrathecal baclofen pharmaceutical dosage forms with fewer degradation products |
| 03/03/2015 | US8969412 Use for a composition comprising chloroprocaine HCL, a new composition comprising chloroprocaine HCL and a method for its manufacture |
| 03/03/2015 | US8969411 Vitamin C composition for use in the prevention and treatment of stretch other skin conditions and methods of using the same |
| 03/03/2015 | US8969397 Systems and methods to treat pain locally |
| 03/03/2015 | US8969385 Ocular formulations of norketotifen |
| 03/03/2015 | US8969379 Pharmaceutical compositions of 4-(3-chloro-4-(cyclopropylaminocarbonyl)aminophenoxy)-7=methoxy-6-quinolinecarboxide |
| 03/03/2015 | US8969369 Abuse-resistant controlled-release opioid dosage form |
| 03/03/2015 | US8969355 1-[2-(2,4 dimethylphenylsulfanyl)-phenyl]piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1a activity for the treatment of cognitive impairment |
| 03/03/2015 | US8969353 Aminoalcohol lipidoids and uses thereof |
| 03/03/2015 | US8969324 Pharmaceutical composition comprising 11-deoxy-prostaglandin compound and method for stabilizing the compound |
| 03/03/2015 | US8969323 Priming solutions for cardiopulmonary bypass |
| 03/03/2015 | US8969320 Hyaluronic acid derivatives containing groups able to release NO |
| 03/03/2015 | US8969319 Agent for applying to mucosa and method for the production thereof |
| 03/03/2015 | US8969310 Potentiation of anticancer agents |
| 03/03/2015 | US8969308 Treatment of T-cell mediated diseases |
| 03/03/2015 | US8969307 Cyclosporin compositions |
| 03/03/2015 | US8969306 Cyclosporin compositions |
| 03/03/2015 | US8969305 Aqueous ophthalmic solution based on cyclosporin |
| 03/03/2015 | US8969298 Liquid preparation of physiologically active peptide |
| 03/03/2015 | US8969293 Therapeutic agent preparations comprising exenatide for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| 03/03/2015 | US8969078 Neural precursor cells produced from bone marrow stromal cells containing an exogenous nucleic acid encoding a notch intracellular domain (NICD) |
| 03/03/2015 | US8968873 Co-flow microfluidic device for polymersome formation |
| 03/03/2015 | US8968872 Encapsulated agglomeration of microcapsules and method for the preparation thereof |
| 03/03/2015 | US8968795 Calcium carbonate granulation |
| 03/03/2015 | US8968794 Antiseptic compositions and uses thereof |
| 03/03/2015 | US8968793 Antiseptic compositions and uses thereof |
| 03/03/2015 | US8968792 Pharmaceutical combination for the treatment of renal failure in pets |
| 03/03/2015 | US8968790 Nanoformulation of vitamin D derivatives and/or vitamin D metabolites |
| 03/03/2015 | US8968788 Granules, tablets and granulation |
| 03/03/2015 | US8968786 Formation of stable submicron peptide or protein particles by thin film freezing |
| 03/03/2015 | US8968785 Surgical compositions |
| 03/03/2015 | US8968784 Method for preparing hydro/organo gelators from disaccharide sugars by biocatalysis and their use in enzyme-triggered drug delivery |
| 03/03/2015 | US8968783 Hydrogel implants with varying degrees of crosslinking |
| 03/03/2015 | US8968782 Combination degradable and non-degradable matrices for active agent delivery |
| 03/03/2015 | US8968781 Therapeutic compositions |
| 03/03/2015 | US8968780 Stabilized pharmaceutical composition |
| 03/03/2015 | US8968779 Controlled release coat-core tablet |
| 03/03/2015 | US8968778 Threo-DOPS controlled release formulation |
| 03/03/2015 | US8968777 Tranexamic acid formulations with reduced adverse effects |
| 03/03/2015 | US8968776 Composition comprising a benzimidazole and process for its manufacture |
| 03/03/2015 | US8968775 Microemulsion topical delivery platform |
| 03/03/2015 | US8968774 Preparation and composition of meloxicam transdermal drug delivery system |
| 03/03/2015 | US8968773 Silicone film former for delivery of actives |
| 03/03/2015 | US8968771 Articles and methods for applying antimicrobial protection |
| 03/03/2015 | US8968770 Multi-part kit comprising a chewing gum and further a flavor containing formulation |
| 03/03/2015 | US8968769 Orally disintegrative dosage form |
| 03/03/2015 | US8968768 Phytosterol nutritional supplements |
| 03/03/2015 | US8968767 Drug depots having different release profiles for reducing, preventing or treating pain and inflammation |
| 03/03/2015 | US8968766 Sustained release intraocular implants containing tyrosine kinase inhibitors and related methods |
| 03/03/2015 | US8968753 Ceftolozane-tazobactam pharmaceutical compositions |
| 03/03/2015 | US8968747 Injection paradigm for administration of botulinum toxins |
| 03/03/2015 | US8968744 Aqueous composition comprising a biological antigen and an acrylic acid polymer |
| 03/03/2015 | US8968743 Method and compositions for cutaneous immunisation |
| 03/03/2015 | US8968725 Genipin cross-linked fibrin gels |
| 03/03/2015 | US8968721 Delivery vehicle for probiotic bacteria comprising a dry matrix of polysaccharides, saccharides and polyols in a glass form and methods of making same |
| 03/03/2015 | US8968715 Drug delivery systems for photodynamic therapy |
| 03/03/2015 | US8968714 Carrier nanoparticles and related compositions, methods and systems |
| 03/03/2015 | US8968710 Topical anesthetic |
| 03/03/2015 | US8968708 Compounds comprising linked heteroaryl moieties and their use as novel umami flavor modifiers, tastants and taste enhancers for comestible compositions |
| 03/03/2015 | US8968707 Composition packaged in an aerosol device, comprising at least one anionic fixing polymer, at least one silicone oxyalkylenated in the alpha and omega positions of the silicone chain, and at least one propellant |
| 03/03/2015 | US8968704 Fluorescent labeling material and fluorescent labeling agent |
| 03/03/2015 | US8968456 Film coating composition from solid powder hydrophobic compounds |
| 03/03/2015 | US8968392 Method of inhibiting vascular intimal hyperplasia using stent |
| 03/03/2015 | US8968274 Acoustically controlled substance delivery device |
| 03/03/2015 | US8967989 Apparatus and process for encapsulating capsules or other solid dosage forms within capsules |
| 02/26/2015 | WO2015027243A2 Biologically active synthetic nanoparticle constructs and mehtods of use therof |
| 02/26/2015 | WO2015027068A1 Dendrimer-resveratrol complex |
| 02/26/2015 | WO2015026851A1 Pharmaceutical composition and use of diethyl (2-cyanoethyl)phosphonate |
| 02/26/2015 | WO2015026813A1 Multi-unit drug delivery devices and methods |
| 02/26/2015 | WO2015026552A2 Mucoadhesive devices for delivery of active agents |
| 02/26/2015 | WO2015026225A1 Bilayer hydrocolloid films containing therapeutic agents |
| 02/26/2015 | WO2015026054A1 Sidenafil citrate orally disintegrating film formulation with improved dispersibility and method for formulating same |
| 02/26/2015 | WO2015025979A1 Method for producing microparticles |
| 02/26/2015 | WO2015025935A1 Cataplasm and method for producing same |
| 02/26/2015 | WO2015025767A1 Transdermal patch |
| 02/26/2015 | WO2015025766A1 Transdermal patch |
| 02/26/2015 | WO2015025718A1 Adhesive patch |
| 02/26/2015 | WO2015025331A2 Drug designing for diabetes mellitus using pentacosanoic acid. |
| 02/26/2015 | WO2015025312A1 Compositions for combined immediate and sustained release of cannabinoids, methods of manufacture and use thereof |
| 02/26/2015 | WO2015025261A1 Duloxetine enteric coated tablet |
| 02/26/2015 | WO2015025119A1 Topical drug patch including microspheres |
| 02/26/2015 | WO2015025061A1 Compounds and formulations for the treatment of wounds |